title: Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
authors: New York State Psychiatric Institute, New York, N.Y., USA.
authors: Michael G
authors: MG
authors: Wheaton
authors: Joseph K
authors: JK
authors: Carpenter
authors: Eyal
authors: E
authors: Kalanthroff
authors: Edna B
authors: EB
authors: Foa
authors: Helen Blair
authors: HB
authors: Simpson
mesh_terms: D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D007171:Implosive Therapy / Q000379:methods; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000628:therapy*; D057240:Patient Preference; D018967:Risperidone / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018967:Risperidone; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors